Crohn's Disease :: FDA approves new treatment for crohn's disease
Health is a unity and harmony within the mind, body and spirit which is unique to each person, and is as defined by that person. The level of wellness or health is, in part, determined by the ability to deal with and defend against stress. Health is determined by physiological, psychological, socio-cultural, spiritual, and developmental stage variables.
logo - spiritindia - Crohn's Disease :: FDA approves new treatment for crohn's disease

FDA approves new treatment for crohn's disease

Crohn's Disease :: FDA approves new treatment for crohn's disease

Crohn's Disease :: FDA approves new treatment for crohn's disease

The Food and Drug Administration (FDA) today approved Humira (adalimumab) to treat adult patients with moderately to severely active Crohn's disease, a chronic inflammatory disease of the intestines, which affects an estimated one million Americans.

Humira is a human-derived, genetically-engineered monoclonal antibody (a protein that can be produced in large quantities in a manufacturing plant). The product acts to reduce excessive levels of human tumor necrosis factor (TNF) alpha, which plays an important role in abnormal inflammatory and immune responses. The labeling includes a boxed warning about potential serious adverse events.

Crohn's disease is a chronic, incurable, inflammatory bowel disease that causes diarrhea, cramping and abdominal pain, and in some cases, abnormal connections (fistulas) leading from the intestine to the skin.

"Humira has been shown to reduce signs and symptoms, and to induce and maintain clinical remission of Crohn's disease in patients who have had an inadequate response to conventional therapy, and in those patients who did not benefit from treatment, or who were intolerant to previous treatment with Remicade (infliximab) therapy," said Dr. Douglas Throckmorton, Deputy Director of FDA's Center for Drug Evaluation and Research. "Today's approval provides patients and their health care providers with a new treatment option.

The product has been studied in 1,478 patients with Crohn's disease in four clinical trials comparing the drug to a placebo (contains no active ingredient) and two longer term extension studies.

The labeling of Humira includes a boxed warning, the strongest type of label warning, that use of this product has been associated with serious, sometimes fatal, infections, including cases of tuberculosis, opportunistic infections, and sepsis. Before initiating Humira treatment, patients should be evaluated for tuberculosis risk factors and tested for latent tuberculosis infection. Other serious adverse events reported by Humira users include lymphoma, a type of cancer. The most frequent adverse events included upper respiratory infections, sinusitis, and nausea.

Humira requires subcutaneous injections (under the skin) to initiate treatment for Crohn's disease, and maintenance treatment is administered as one injection every other week.

Humira was previously approved for the treatment of three autoimmune diseases: rheumatoid arthritis, a chronic inflammation of the joints; psoriatic arthritis, which causes joint swelling and scaly skin; and ankylosing spondylitis, a systemic rheumatic disease that affects the spine and sacroiliac joints. Humira is manufactured by Abbott Laboratories, Abbott Park, Ill.




(Crohn's Disease :: FDA approves new treatment for crohn's disease published at SpiritIndia on Tuesday, February 27, 2007)



Crohn's Disease

Search more information on Crohn's Disease, Crohn's Disease books

Recently posted related articles on Crohn's Disease :

  1. Crohn's Disease :: Pharmaceutical Benefits scheme change for Crohn's disease
  2. Crohn's Disease :: Remicade receives EU approval for pediatric Crohn's Disease
  3. Crohn's Disease :: Genetic susceptibility to Crohn's disease
  4. Crohn's Disease :: Smoking influences Crohn's disease
  5. Crohn's Disease :: Abbott's Humira for treatment of Crohn's disease
  6. Crohn's Disease :: Scientists find major susceptibility gene for Crohn's disease
  7. Crohn's Disease :: Scientists find new genes for Crohn's disease
  8. Crohn's Disease :: Genetic risk factors for Crohn's disease identified
  9. Crohn's Disease :: Remicade - Treatment for Pediatric Crohn's Disease
  10. Crohn's Disease :: FDA approves new treatment for crohn's disease

Most related articles:

- Crohn's Disease :: FDA approves new treatment for crohn's disease
- Crohn's Disease :: Abbott's Humira for treatment of Crohn's disease - 15.8
- Crohn's Disease :: Vitamin D high in Crohn's disease patients - 15.2
- Crohn's Disease :: Pharmaceutical Benefits scheme change for Crohn's disease - 14.7
- Crohn's disease :: Vitamin D, calcium ok for crohn's-related bone loss - 13.7
- Pregnancy :: Inflammatory bowel disease doubles pregnancy complications - 13.7
- Crohn's Disease :: Naltrexone therapy improves active Crohn's Disease - 13.4
- Crohn's Disease :: Remicade - Treatment for Pediatric Crohn's Disease - 12.6
- Crohn's Disease :: Smoking influences Crohn's disease - 11.9
- Crohn's Disease :: Remicade receives EU approval for pediatric Crohn's Disease - 11.5


Crohn's Disease - recent related articles/news stories:

- Cimzia in prefilled syringe for Crohn's disease patients
- Safer effective way to treat Crohn's disease
- Cows milk may cause Crohn's disease

»»   Bird Flu Vaccine :: Sanofi bird flu vaccine supported by FDA panel
««   Healthcare :: FDA clears Baxter Healthcare's modified infusion pump






Tools
Daily calorie need
Homeo tips
Homeo softwares
Associations
NHMC Alumni
IFH
PHS
Vital Informer
Articles & news
Education
Homeo articles
Homeopathy cases
Homeopathic Remedies
You
Authors
Submit article
Your account
Testimonials
About
About us
Advertisers
Advertising
Linking us
Disclaimer
Privacy policy

The information provided on SpiritIndia.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Spirit India comply with the HONcode principles for trustworthy health information.
Health, Business, Science, Sports, Entertainment, Technology
©2002-2009 SpiritIndia.com